svmpharma-limited documents

SVMPharma NHS – SVMPharma has launched its NEW NHS services

Healthcare SVMPharma NHS – SVMPharma has launched its NEW NHS services

SVMPharma Real World Evidence - RWE Series Part I: Real World Evidence and Why it Matters

Healthcare SVMPharma Real World Evidence - RWE Series Part I: Real World Evidence and Why it Matters

SVMPharma Real World Evidence – The RWE Series – Part IV: Where does Real World Evidence fit within the Product Lifecycle?

Healthcare SVMPharma Real World Evidence – The RWE Series – Part IV: Where does Real World Evidence fit within the Product Lifecycle?

SVMPharma Real World Evidence – Data Governance For UK RWE: What Do You Need To Know?

Healthcare SVMPharma Real World Evidence – Data Governance For UK RWE: What Do You Need To Know?

SVMPharma Real World Evidence – Real World Evidence (RWE): Getting Started With Your First Project

Healthcare SVMPharma Real World Evidence – Real World Evidence (RWE): Getting Started With Your First Project

SVMPharma Real World Evidence – Real World Evidence as a driver of HTA approval: Can you afford to miss out?

Healthcare SVMPharma Real World Evidence – Real World Evidence as a driver of HTA approval: Can you afford to miss out?

SVMPharma Real World Evidence – Real World Evidence (RWE) From Concept To Action: A Timeline

Healthcare SVMPharma Real World Evidence – Real World Evidence (RWE) From Concept To Action: A Timeline

SVMPharma Real World Evidence - Looking after your data: The importance of Data Governance

Healthcare SVMPharma Real World Evidence - Looking after your data: The importance of Data Governance

SVMPharma Real World Evidence – The RWE Series – Part II: Collecting Real World Evidence

Healthcare SVMPharma Real World Evidence – The RWE Series – Part II: Collecting Real World Evidence

SVMPharma Real World Evidence – Real World Data Across the Product Lifecycle: RWE from pre-clinical to launch

Healthcare SVMPharma Real World Evidence – Real World Data Across the Product Lifecycle: RWE from pre-clinical to launch

Healthcare SVMPharma NHS – Any 1 of 35 Commissioning for Quality and Innovation (CQUINs) could be directly affected by YOUR BRAND

SVMPharma Real World Evidence – European initiatives for Real World Evidence

Healthcare SVMPharma Real World Evidence – European initiatives for Real World Evidence

SVMPharma NHS - Choice or Ignorance? 87% of ABPI members ignored NHS mandate consultation

Healthcare SVMPharma NHS - Choice or Ignorance? 87% of ABPI members ignored NHS mandate consultation

SVMPharma NHS - How can you understand the NHS if you don’t understand their mandate?

Healthcare SVMPharma NHS - How can you understand the NHS if you don’t understand their mandate?

SVMPharma Real World Evidence – Why NHS must embrace Real World Data

Health & Medicine SVMPharma Real World Evidence – Why NHS must embrace Real World Data

Real World Initiatives: Increasing RWE availability across Europe

Healthcare Real World Initiatives: Increasing RWE availability across Europe

SVMPharma NHS - Is it time to get rid of NHS targets?

Healthcare SVMPharma NHS - Is it time to get rid of NHS targets?

SVMPharma Real World Evidence - eyeforpharma Amsterdam 2016: RWE Patient level data at every stage of the drug life cycle

Healthcare SVMPharma Real World Evidence - eyeforpharma Amsterdam 2016: RWE Patient level data at every stage of the drug life cycle

SVMPharma Real World Evidence – Afraid Of Non-Randomised Data?

Healthcare SVMPharma Real World Evidence – Afraid Of Non-Randomised Data?

SVMPharma Real World Evidence - NHS England endorses Real World Evidence for the Cancer Drugs Fund and NICE

Healthcare SVMPharma Real World Evidence - NHS England endorses Real World Evidence for the Cancer Drugs Fund and NICE

SVMPharma Real World Evidence – NICE and the NHS are changing the way they look at cost-effective and innovative drugs in the UK

Healthcare SVMPharma Real World Evidence – NICE and the NHS are changing the way they look at cost-effective and innovative drugs in the UK

Next >